LPA1 Antagonism by PIPE-791 Reduces Alveolar Epithelial Cell Apoptosis In Vitro

/in , /by

Michael M. Poon, Alexander R. Broadhead, Christopher S. Baccei, Didier Bagnol, Jeffrey R. Roppe, Thomas O. Schrader, Lino Valdez, Yifeng Xiong, Austin C. Chen, Timothy R. Watkins, Daniel S. Lorrain

Presented at ATS 2026

PIPE-791 and BMS-986278: Two Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists with Distinct Lung Occupancy Profiles and Vascular Effects

/in , /by

Daniel S. Lorrain, Michael M. Poon, Kym I. Lorrain, Alexander R. Broadhead, Didier Bagnol, Jeffrey R. Roppe, Thomas O. Schrader, Austin C. Chen

Presented at ATS 2026

Exploring the Effects of SARM1 Inhibition in Preventing Neurodegeneration in Human and Rodent Neuropathic Pain Models

/in , /by

Cameron Pernia, Geraldine Edu, Kymmy Lorrain, Greg Joseph, Didier Bagnol, Thomas Schrader, Michael Poon, Daniel Lorrain

Presented at American College of Neuropsychopharmacology 2025

LPA1 Expression in CNS Fibroblasts During Multiple Sclerosis

/in , /by

Michael M. Poon, Didier Bagnol, Austin C. Chen, Daniel S. Lorrain

Presented at ACTRIMS Forum 2026

©2026 Contineum Therapeutics Terms of Use Privacy Policy Linkedin Linkedin